Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter.
Year: 2023
Type: article
Abstract: No AccessJournal of UrologyLetters to the Editor1 Apr 2023Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter. Peris R. Castaneda, Michael Ahdoot, and Charles J. Rosser Peris R. CastanedaPeris R. Castaneda https://orcid.org/0000-0003-1736-0574 Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California More articles by this author , Michael AhdootMichael Ahdoot Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California More articles by this author , and Charles J. RosserCharles J. Rosser Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003362AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Letter.." The Journal of Urology, 209(4), pp. 678–679 REFERENCES 1. . Repeat transurethral resection of muscle-invasive bladder cancer prior to radical cystectomy is prognostic but not therapeutic. J Urol. 2023; 209(1):140-149. Link, Google Scholar 2. . Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol. 2016; 196(4):1021-1029. Link, Google Scholar 3. ; Edinburgh Uro-Oncology Group. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010; 57(5):843-849. Crossref, Medline, Google Scholar 4. . Survival and oncologic outcomes of complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urol Oncol. 2021; 39(11):787.e9-787.e15. Crossref, Medline, Google Scholar 5. . Is exam under anesthesia still necessary for the staging of bladder cancer in the era of modern imaging?. Bladder Cancer. 2015; 1(1):91-96. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue 4April 2023Page: 678-679 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Peris R. Castaneda Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California More articles by this author Michael Ahdoot Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California More articles by this author Charles J. Rosser Division of Urology, Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California More articles by this author Expand All Advertisement PDF downloadLoading ...
Source: The Journal of Urology
Institution: Cedars-Sinai Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: G762397376
OpenAlex ID: W4319457624